DysmenorrheaNCT07852143
Heavy Menstrual Bleeding and Dysmenorrhea Among Undergraduate Females in the Faculty of Medicine of Assiut University
An observational study of Dysmenorrhea and Heavy Menstrual Bleeding, run by Assiut University.
Trial summary
Menstrual disorders, particularly dysmenorrhea (painful menstruation) and heavy menstrual bleeding (excessive menstrual blood loss), are common conditions among young adult females that can substantially impact quality of life, university attendance, and academic performance. Read more about this study
- Who is it for?
- Ages 18 years and older, women only
- Conditions the study is for
- Dysmenorrhea, Heavy Menstrual Bleeding, Menorrhagia
- How many people
- 486 participants
- Where
- No sites listed yet
- Study dates
- Oct 2026to Nov 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Adult, Older adult
Study population: Undergraduate female medical students enrolled in the Faculty of Medicine at Assiut University, Assiut, Egypt. Eligible participants are nulliparous and nulligravid female students recruited on campus during non-learning hours to complete face-to-face interviews and menstrual symptom assessments.
Who may be able to join
- Undergraduate female students enrolled in the Faculty of Medicine, Assiut University
- Nulliparous and nulligravid females
Who cannot join
- History of previous pregnancy or childbirth (currently gravid or parous females)
- Students enrolled in non-medical faculties or postgraduate academic programs
- Refusal or inability to complete the interview questionnaire or the Pictorial Blood Loss Assessment Chart (PBLAC)
About this study
Official title: Prevalence of Heavy Menstrual Bleeding and Intensity of Dysmenorrhea Among Undergraduate Females in the Faculty of Medicine of Assiut University
Menstrual disorders, particularly dysmenorrhea (painful menstruation) and heavy menstrual bleeding (excessive menstrual blood loss), are common conditions among young adult females that can substantially impact quality of life, university attendance, and academic performance. This study aims to evaluate the prevalence of heavy menstrual bleeding and determine the intensity of dysmenorrhea among undergraduate female medical students at Assiut University.
Participants in this cross-sectional observational study include nulliparous and nulligravid female undergraduate students enrolled in the Faculty of Medicine. Data collection involves face-to-face interviews and self-completed assessment instruments during non-instructional hours. Dysmenorrhea severity, pain characteristics, and related functional impairment are evaluated using the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) score. Menstrual blood volume is quantified using the Pictorial Blood Loss Assessment Chart (PBLAC) during the menstrual period to identify heavy menstrual bleeding. Additionally, the study assesses associated physical symptoms, academic absenteeism, and common pharmacological and non-pharmacological management strategies utilized by the participants.
- Conditions
- Dysmenorrhea, Heavy Menstrual Bleeding, Menorrhagia
- Keywords
- WaLIDD Score, Pictorial Blood Loss Assessment Chart, PBLAC, Primary Dysmenorrhea, Menstrual Disorders, Absenteeism, Medical Students
- Medical subject headings
- Dysmenorrhea, Menorrhagia, Menstruation Disturbances
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Female Undergraduate Medical Students | Nulliparous and nulligravid undergraduate female students enrolled in the Faculty of Medicine at Assiut University. Participants complete an adapted semi-structured questionnaire incorporating the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) scale to assess dysmenorrhea severity, associated symptoms, academic impact, and management practices. In addition, participants evaluate menstrual blood loss during their menstrual cycle using the Pictorial Blood Loss Assessment Chart (PBLAC) to determine the prevalence of heavy menstrual bleeding. No therapeutic or experimental intervention is administered. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Dysmenorrhea Severity Assessed by the WaLIDD Score
Assessed using the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) score. The instrument evaluates 4 domains: study/work ability (0 to 3), anatomical pain locations (0 to 3), pain intensity (0 to 3), and duration of pain in days (0 to 3). The total score ranges from 0 to 12 points, categorized as follows: 0 indicates no dysmenorrhea, 1 to 4 indicates mild dysmenorrhea, 5 to 7 indicates moderate dysmenorrhea, and 8 to 12 indicates severe dysmenorrhea. Higher scores reflect greater symptom severity and functional impairment.
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Oct 2026
- Study startOct 2026 (estimated)
- Primary completionOct 2027 (estimated)
- Study completionNov 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DysmenorrheaStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 486 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ghada Rady Ghyt, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07852143
- Sponsor's protocol ID
- HMB and Dysmenorrhea in Assiut
- Status last verified
- Sep 2026
- First submitted
- 25 Sep 2026
- Last updated
- 1 Oct 2026
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Heavy Menstrual Bleeding and Intensity of Dysmenorrhea Among Undergraduate Females in the Faculty of Medicine of Assiut University
- ClinicalTrials.gov ID
- NCT07852143
- Acronym / sponsor ID
- HMB and Dysmenorrhea in Assiut
- Conditions
- Dysmenorrhea, Heavy Menstrual Bleeding, Menorrhagia
- Keywords
- WaLIDD Score, Pictorial Blood Loss Assessment Chart, PBLAC, Primary Dysmenorrhea, Menstrual Disorders, Absenteeism, Medical Students
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 486 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- Oct 2026 (estimated)
- Primary completion
- Oct 2027 (estimated)
- Study completion
- Nov 2027 (estimated)
- First posted
- 1 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Menstrual disorders, particularly dysmenorrhea (painful menstruation) and heavy menstrual bleeding (excessive menstrual blood loss), are common conditions among young adult females that can substantially impact quality of life, university attendance, and academic performance. This study aims to evaluate the prevalence of heavy menstrual bleeding and determine the intensity of dysmenorrhea among undergraduate female medical students at Assiut University.
Participants in this cross-sectional observational study include nulliparous and nulligravid female undergraduate students enrolled in the Faculty of Medicine. Data collection involves face-to-face interviews and self-completed assessment instruments during non-instructional hours. Dysmenorrhea severity, pain characteristics, and related functional impairment are evaluated using the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) score. Menstrual blood volume is quantified using the Pictorial Blood Loss Assessment Chart (PBLAC) during the menstrual period to identify heavy menstrual bleeding. Additionally, the study assesses associated physical symptoms, academic absenteeism, and common pharmacological and non-pharmacological management strategies utilized by the participants.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Female Undergraduate Medical Students | – | –Nulliparous and nulligravid undergraduate female students enrolled in the Faculty of Medicine at Assiut University. Participants complete an adapted semi-structured questionnaire incorporating the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) scale to assess dysmenorrhea severity, associated symptoms, academic impact, and management practices. In addition, participants evaluate menstrual blood loss during their menstrual cycle using the Pictorial Blood Loss Assessment Chart (PBLAC) to determine the prevalence of heavy menstrual bleeding. No therapeutic or experimental intervention is administered. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Age groups
- Adult, Older adult
- Study population
- Undergraduate female medical students enrolled in the Faculty of Medicine at Assiut University, Assiut, Egypt. Eligible participants are nulliparous and nulligravid female students recruited on campus during non-learning hours to complete face-to-face interviews and menstrual symptom assessments.
Key inclusion criteria (2 listed)
- Undergraduate female students enrolled in the Faculty of Medicine, Assiut University
- Nulliparous and nulligravid females
Key exclusion criteria (3 listed)
- History of previous pregnancy or childbirth (currently gravid or parous females)
- Students enrolled in non-medical faculties or postgraduate academic programs
- Refusal or inability to complete the interview questionnaire or the Pictorial Blood Loss Assessment Chart (PBLAC)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Dysmenorrhea Severity Assessed by the WaLIDD Score
Time frame: Baseline
Assessed using the Working ability, Location, Intensity, Days of pain and Dysmenorrhea (WaLIDD) score. The instrument evaluates 4 domains: study/work ability (0 to 3), anatomical pain locations (0 to 3), pain intensity (0 to 3), and duration of pain in days (0 to 3). The total score ranges from 0 to 12 points, categorized as follows: 0 indicates no dysmenorrhea, 1 to 4 indicates mild dysmenorrhea, 5 to 7 indicates moderate dysmenorrhea, and 8 to 12 indicates severe dysmenorrhea. Higher scores reflect greater symptom severity and functional impairment.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Oct 2026.
Related trials for Dysmenorrhea
Not yet recruiting
Radiofrequency and Pelvic Floor Exercise for Primary Dysmenorrhea
Primary Dysmenorrhea
Not yet recruitingPhase 2
PRECISION-E2: Teverelix in Women With Endometriosis - Pharmacodynamics, Safety and Precision Medicine Correlates
Endometriosis Pelvic, Endometriosis Ovaries
Not yet recruiting
Ultrasound-Guided Radiofrequency Ablation for Focal Adenomyosis
Adenomyosis, Adenomyoma of Uterus
Active, not recruiting
Mindfulness-Based Education For Women With Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS), Menstrual Symptoms
Not yet recruiting
The Effect of a Ginger Formula on Menstrual Health vs a Placebo
Painful Menstruation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Dysmenorrhea and Heavy Menstrual Bleeding, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 1 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Dysmenorrhea Severity Assessed by the WaLIDD Score (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2026.